ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glucosamine Sulfate API Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-30R17221
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Glucosamine Sulfate API Market Research Report 2024
BUY CHAPTERS

Global Glucosamine Sulfate API Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-30R17221
Report
October 2025
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BIOIBERICA
Andhra Medi Pharma
Panvo Organics
TSI
Yangzhou Rixing Bio-Tech
Shandong Runde Biotechnology
Fujian huakang pharmaceutical
Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
Jiangsu Shuanglin Marine Biological Pharmaceutical

Glucosamine Sulfate API Market

The global Glucosamine Sulfate API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Glucosamine is a natural compound found in cartilage — the tough tissue that cushions joints. Since glucosamine has an active amino group and its chemical properties are not very stable, the glucosamine compounds commonly used on the market currently exist mainly in the form of glucosamine hydrochloride, glucosamine sulfate and their complex salts.
Glucosamine sulfate is a natural amino monosaccharide and an important component necessary for the synthesis of proteoglycans in the matrix of human articular cartilage. It can repair cartilage, promote the formation of synovial fluid, and effectively inhibit the inflammatory process.
From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Glucosamine Sulfate API leading manufacturers including Bioiberica, Andhra Medi Pharma, Panvo Organics, TSI, Yangzhou Rixing Bio-tech, Shandong Runde Biotechnology, Fujian huakang pharmaceutical, Zhejiang Zhoushan Putuo Xinxing Pharmaceutical, Jiangsu Shuanglin Marine Biological Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Bioiberica leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Glucosamine Sulfate API market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Glucosamine Sulfate API Market Report

Report Metric Details
Report Name Glucosamine Sulfate API Market
Segment by Type
  • Glucosamine Sulfate Sodium Salt
  • Glucosamine Sulfate Potassium Salt
Segment by Application
  • Pharmaceutical
  • Health Products
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bioiberica, Andhra Medi Pharma, Panvo Organics, TSI, Yangzhou Rixing Bio-tech, Shandong Runde Biotechnology, Fujian huakang pharmaceutical, Zhejiang Zhoushan Putuo Xinxing Pharmaceutical, Jiangsu Shuanglin Marine Biological Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Glucosamine Sulfate API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Glucosamine Sulfate API Market report?

Ans: The main players in the Glucosamine Sulfate API Market are Bioiberica, Andhra Medi Pharma, Panvo Organics, TSI, Yangzhou Rixing Bio-tech, Shandong Runde Biotechnology, Fujian huakang pharmaceutical, Zhejiang Zhoushan Putuo Xinxing Pharmaceutical, Jiangsu Shuanglin Marine Biological Pharmaceutical

What are the Application segmentation covered in the Glucosamine Sulfate API Market report?

Ans: The Applications covered in the Glucosamine Sulfate API Market report are Pharmaceutical, Health Products

What are the Type segmentation covered in the Glucosamine Sulfate API Market report?

Ans: The Types covered in the Glucosamine Sulfate API Market report are Glucosamine Sulfate Sodium Salt, Glucosamine Sulfate Potassium Salt

1 Study Coverage
1.1 Introduction to Glucosamine Sulfate API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Glucosamine Sulfate API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Glucosamine Sulfate Sodium Salt
1.2.3 Glucosamine Sulfate Potassium Salt
1.3 Market Segmentation by Application
1.3.1 Global Glucosamine Sulfate API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Health Products
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glucosamine Sulfate API Revenue Estimates and Forecasts 2020-2031
2.2 Global Glucosamine Sulfate API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Glucosamine Sulfate API Sales Estimates and Forecasts 2020-2031
2.4 Global Glucosamine Sulfate API Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Glucosamine Sulfate API Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Glucosamine Sulfate API Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Glucosamine Sulfate Sodium Salt Market Size by Manufacturers
3.5.2 Glucosamine Sulfate Potassium Salt Market Size by Manufacturers
3.6 Global Glucosamine Sulfate API Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Glucosamine Sulfate API Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Glucosamine Sulfate API Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Glucosamine Sulfate API Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Glucosamine Sulfate API Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Glucosamine Sulfate API Sales and Revenue by Type (2020-2031)
6.4 North America Glucosamine Sulfate API Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Glucosamine Sulfate API Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Glucosamine Sulfate API Sales and Revenue by Type (2020-2031)
7.4 Europe Glucosamine Sulfate API Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Glucosamine Sulfate API Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Glucosamine Sulfate API Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Glucosamine Sulfate API Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Glucosamine Sulfate API Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Glucosamine Sulfate API Sales and Revenue by Type (2020-2031)
9.4 Central and South America Glucosamine Sulfate API Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Glucosamine Sulfate API Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Glucosamine Sulfate API Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Glucosamine Sulfate API Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Glucosamine Sulfate API Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bioiberica
11.1.1 Bioiberica Corporation Information
11.1.2 Bioiberica Business Overview
11.1.3 Bioiberica Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.1.4 Bioiberica Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bioiberica Glucosamine Sulfate API Sales by Product in 2024
11.1.6 Bioiberica Glucosamine Sulfate API Sales by Application in 2024
11.1.7 Bioiberica Glucosamine Sulfate API Sales by Geographic Area in 2024
11.1.8 Bioiberica Glucosamine Sulfate API SWOT Analysis
11.1.9 Bioiberica Recent Developments
11.2 Andhra Medi Pharma
11.2.1 Andhra Medi Pharma Corporation Information
11.2.2 Andhra Medi Pharma Business Overview
11.2.3 Andhra Medi Pharma Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.2.4 Andhra Medi Pharma Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Andhra Medi Pharma Glucosamine Sulfate API Sales by Product in 2024
11.2.6 Andhra Medi Pharma Glucosamine Sulfate API Sales by Application in 2024
11.2.7 Andhra Medi Pharma Glucosamine Sulfate API Sales by Geographic Area in 2024
11.2.8 Andhra Medi Pharma Glucosamine Sulfate API SWOT Analysis
11.2.9 Andhra Medi Pharma Recent Developments
11.3 Panvo Organics
11.3.1 Panvo Organics Corporation Information
11.3.2 Panvo Organics Business Overview
11.3.3 Panvo Organics Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.3.4 Panvo Organics Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Panvo Organics Glucosamine Sulfate API Sales by Product in 2024
11.3.6 Panvo Organics Glucosamine Sulfate API Sales by Application in 2024
11.3.7 Panvo Organics Glucosamine Sulfate API Sales by Geographic Area in 2024
11.3.8 Panvo Organics Glucosamine Sulfate API SWOT Analysis
11.3.9 Panvo Organics Recent Developments
11.4 TSI
11.4.1 TSI Corporation Information
11.4.2 TSI Business Overview
11.4.3 TSI Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.4.4 TSI Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 TSI Glucosamine Sulfate API Sales by Product in 2024
11.4.6 TSI Glucosamine Sulfate API Sales by Application in 2024
11.4.7 TSI Glucosamine Sulfate API Sales by Geographic Area in 2024
11.4.8 TSI Glucosamine Sulfate API SWOT Analysis
11.4.9 TSI Recent Developments
11.5 Yangzhou Rixing Bio-tech
11.5.1 Yangzhou Rixing Bio-tech Corporation Information
11.5.2 Yangzhou Rixing Bio-tech Business Overview
11.5.3 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.5.4 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Sales by Product in 2024
11.5.6 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Sales by Application in 2024
11.5.7 Yangzhou Rixing Bio-tech Glucosamine Sulfate API Sales by Geographic Area in 2024
11.5.8 Yangzhou Rixing Bio-tech Glucosamine Sulfate API SWOT Analysis
11.5.9 Yangzhou Rixing Bio-tech Recent Developments
11.6 Shandong Runde Biotechnology
11.6.1 Shandong Runde Biotechnology Corporation Information
11.6.2 Shandong Runde Biotechnology Business Overview
11.6.3 Shandong Runde Biotechnology Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.6.4 Shandong Runde Biotechnology Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shandong Runde Biotechnology Recent Developments
11.7 Fujian huakang pharmaceutical
11.7.1 Fujian huakang pharmaceutical Corporation Information
11.7.2 Fujian huakang pharmaceutical Business Overview
11.7.3 Fujian huakang pharmaceutical Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.7.4 Fujian huakang pharmaceutical Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Fujian huakang pharmaceutical Recent Developments
11.8 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
11.8.1 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Corporation Information
11.8.2 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Business Overview
11.8.3 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.8.4 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Recent Developments
11.9 Jiangsu Shuanglin Marine Biological Pharmaceutical
11.9.1 Jiangsu Shuanglin Marine Biological Pharmaceutical Corporation Information
11.9.2 Jiangsu Shuanglin Marine Biological Pharmaceutical Business Overview
11.9.3 Jiangsu Shuanglin Marine Biological Pharmaceutical Glucosamine Sulfate API Product Models, Descriptions and Specifications
11.9.4 Jiangsu Shuanglin Marine Biological Pharmaceutical Glucosamine Sulfate API Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Jiangsu Shuanglin Marine Biological Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Glucosamine Sulfate API Industry Chain
12.2 Glucosamine Sulfate API Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Glucosamine Sulfate API Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Glucosamine Sulfate API Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Glucosamine Sulfate API Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Glucosamine Sulfate API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
BIOIBERICA
Andhra Medi Pharma
Panvo Organics
TSI
Yangzhou Rixing Bio-Tech
Shandong Runde Biotechnology
Fujian huakang pharmaceutical
Zhejiang Zhoushan Putuo Xinxing Pharmaceutical
Jiangsu Shuanglin Marine Biological Pharmaceutical
List of Tables
 Table 1. Global Glucosamine Sulfate API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Glucosamine Sulfate API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Glucosamine Sulfate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Glucosamine Sulfate API Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Glucosamine Sulfate API Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Glucosamine Sulfate API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Glucosamine Sulfate API Sales by Region (2020-2025) & (Tons)
 Table 8. Global Glucosamine Sulfate API Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Glucosamine Sulfate API Sales by Manufacturers (2020-2025) & (Tons)
 Table 11. Global Glucosamine Sulfate API Sales Share by Manufacturers (2020-2025)
 Table 12. Global Glucosamine Sulfate API Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Glucosamine Sulfate API Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Glucosamine Sulfate API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucosamine Sulfate API as of 2024)
 Table 16. Global Glucosamine Sulfate API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Glucosamine Sulfate API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 18. Key Manufacturers Glucosamine Sulfate API Manufacturing Base and Headquarters
 Table 19. Global Glucosamine Sulfate API Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Glucosamine Sulfate API Sales by Type (2020-2025) & (Tons)
 Table 23. Global Glucosamine Sulfate API Sales by Type (2026-2031) & (Tons)
 Table 24. Global Glucosamine Sulfate API Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Glucosamine Sulfate API Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Glucosamine Sulfate API ASP by Type (2020-2031) & (US$/Ton)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Glucosamine Sulfate API Sales by Application (2020-2025) & (Tons)
 Table 29. Global Glucosamine Sulfate API Sales by Application (2026-2031) & (Tons)
 Table 30. Glucosamine Sulfate API High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Glucosamine Sulfate API Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Glucosamine Sulfate API Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Glucosamine Sulfate API ASP by Application (2020-2031) & (US$/Ton)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Glucosamine Sulfate API Growth Accelerators and Market Barriers
 Table 37. North America Glucosamine Sulfate API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Glucosamine Sulfate API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Glucosamine Sulfate API Growth Accelerators and Market Barriers
 Table 40. Europe Glucosamine Sulfate API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Glucosamine Sulfate API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Glucosamine Sulfate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Glucosamine Sulfate API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Glucosamine Sulfate API Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Glucosamine Sulfate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Glucosamine Sulfate API Investment Opportunities and Key Challenges
 Table 47. Central and South America Glucosamine Sulfate API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Glucosamine Sulfate API Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Glucosamine Sulfate API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Bioiberica Corporation Information
 Table 51. Bioiberica Description and Major Businesses
 Table 52. Bioiberica Product Models, Descriptions and Specifications
 Table 53. Bioiberica Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 54. Bioiberica Sales Value Proportion by Product in 2024
 Table 55. Bioiberica Sales Value Proportion by Application in 2024
 Table 56. Bioiberica Sales Value Proportion by Geographic Area in 2024
 Table 57. Bioiberica Glucosamine Sulfate API SWOT Analysis
 Table 58. Bioiberica Recent Developments
 Table 59. Andhra Medi Pharma Corporation Information
 Table 60. Andhra Medi Pharma Description and Major Businesses
 Table 61. Andhra Medi Pharma Product Models, Descriptions and Specifications
 Table 62. Andhra Medi Pharma Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 63. Andhra Medi Pharma Sales Value Proportion by Product in 2024
 Table 64. Andhra Medi Pharma Sales Value Proportion by Application in 2024
 Table 65. Andhra Medi Pharma Sales Value Proportion by Geographic Area in 2024
 Table 66. Andhra Medi Pharma Glucosamine Sulfate API SWOT Analysis
 Table 67. Andhra Medi Pharma Recent Developments
 Table 68. Panvo Organics Corporation Information
 Table 69. Panvo Organics Description and Major Businesses
 Table 70. Panvo Organics Product Models, Descriptions and Specifications
 Table 71. Panvo Organics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 72. Panvo Organics Sales Value Proportion by Product in 2024
 Table 73. Panvo Organics Sales Value Proportion by Application in 2024
 Table 74. Panvo Organics Sales Value Proportion by Geographic Area in 2024
 Table 75. Panvo Organics Glucosamine Sulfate API SWOT Analysis
 Table 76. Panvo Organics Recent Developments
 Table 77. TSI Corporation Information
 Table 78. TSI Description and Major Businesses
 Table 79. TSI Product Models, Descriptions and Specifications
 Table 80. TSI Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 81. TSI Sales Value Proportion by Product in 2024
 Table 82. TSI Sales Value Proportion by Application in 2024
 Table 83. TSI Sales Value Proportion by Geographic Area in 2024
 Table 84. TSI Glucosamine Sulfate API SWOT Analysis
 Table 85. TSI Recent Developments
 Table 86. Yangzhou Rixing Bio-tech Corporation Information
 Table 87. Yangzhou Rixing Bio-tech Description and Major Businesses
 Table 88. Yangzhou Rixing Bio-tech Product Models, Descriptions and Specifications
 Table 89. Yangzhou Rixing Bio-tech Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 90. Yangzhou Rixing Bio-tech Sales Value Proportion by Product in 2024
 Table 91. Yangzhou Rixing Bio-tech Sales Value Proportion by Application in 2024
 Table 92. Yangzhou Rixing Bio-tech Sales Value Proportion by Geographic Area in 2024
 Table 93. Yangzhou Rixing Bio-tech Glucosamine Sulfate API SWOT Analysis
 Table 94. Yangzhou Rixing Bio-tech Recent Developments
 Table 95. Shandong Runde Biotechnology Corporation Information
 Table 96. Shandong Runde Biotechnology Description and Major Businesses
 Table 97. Shandong Runde Biotechnology Product Models, Descriptions and Specifications
 Table 98. Shandong Runde Biotechnology Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 99. Shandong Runde Biotechnology Recent Developments
 Table 100. Fujian huakang pharmaceutical Corporation Information
 Table 101. Fujian huakang pharmaceutical Description and Major Businesses
 Table 102. Fujian huakang pharmaceutical Product Models, Descriptions and Specifications
 Table 103. Fujian huakang pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 104. Fujian huakang pharmaceutical Recent Developments
 Table 105. Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Corporation Information
 Table 106. Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Description and Major Businesses
 Table 107. Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Product Models, Descriptions and Specifications
 Table 108. Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 109. Zhejiang Zhoushan Putuo Xinxing Pharmaceutical Recent Developments
 Table 110. Jiangsu Shuanglin Marine Biological Pharmaceutical Corporation Information
 Table 111. Jiangsu Shuanglin Marine Biological Pharmaceutical Description and Major Businesses
 Table 112. Jiangsu Shuanglin Marine Biological Pharmaceutical Product Models, Descriptions and Specifications
 Table 113. Jiangsu Shuanglin Marine Biological Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 114. Jiangsu Shuanglin Marine Biological Pharmaceutical Recent Developments
 Table 115. Key Raw Materials Distribution
 Table 116. Raw Materials Key Suppliers
 Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 118. Milestones in Production Technology Evolution
 Table 119. Distributors List
 Table 120. Market Trends and Market Evolution
 Table 121. Market Drivers and Opportunities
 Table 122. Market Challenges, Risks, and Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources


List of Figures
 Figure 1. Glucosamine Sulfate API Product Picture
 Figure 2. Global Glucosamine Sulfate API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Glucosamine Sulfate Sodium Salt Product Picture
 Figure 4. Glucosamine Sulfate Potassium Salt Product Picture
 Figure 5. Global Glucosamine Sulfate API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pharmaceutical
 Figure 7. Health Products
 Figure 8. Glucosamine Sulfate API Report Years Considered
 Figure 9. Global Glucosamine Sulfate API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Glucosamine Sulfate API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Glucosamine Sulfate API Revenue Market Share by Region (2020-2031)
 Figure 13. Global Glucosamine Sulfate API Sales (2020-2031) & (Tons)
 Figure 14. Global Glucosamine Sulfate API Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 15. Global Glucosamine Sulfate API Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Glucosamine Sulfate API Sales Volume Market Share in 2024
 Figure 17. Global Glucosamine Sulfate API Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Glucosamine Sulfate Sodium Salt Revenue Market Share by Manufacturer in 2024
 Figure 20. Glucosamine Sulfate Potassium Salt Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Glucosamine Sulfate API Sales Market Share by Type (2020-2031)
 Figure 22. Global Glucosamine Sulfate API Revenue Market Share by Type (2020-2031)
 Figure 23. Global Glucosamine Sulfate API Sales Market Share by Application (2020-2031)
 Figure 24. Global Glucosamine Sulfate API Revenue Market Share by Application (2020-2031)
 Figure 25. North America Glucosamine Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 26. North America Glucosamine Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Glucosamine Sulfate API Sales Revenue (US$ Million) in 2024
 Figure 28. North America Glucosamine Sulfate API Sales Volume (Tons) by Type (2020- 2031)
 Figure 29. North America Glucosamine Sulfate API Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Glucosamine Sulfate API Sales Volume (Tons) by Application (2020-2031)
 Figure 31. North America Glucosamine Sulfate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Glucosamine Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 36. Europe Glucosamine Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Glucosamine Sulfate API Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Glucosamine Sulfate API Sales Volume (Tons) by Type (2020-2031)
 Figure 39. Europe Glucosamine Sulfate API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Glucosamine Sulfate API Sales Volume (Tons) by Application (2020-2031)
 Figure 41. Europe Glucosamine Sulfate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 43. France Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Glucosamine Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 48. Asia-Pacific Glucosamine Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Glucosamine Sulfate API Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Glucosamine Sulfate API Sales Volume (Tons) by Type (2020- 2031)
 Figure 51. Asia-Pacific Glucosamine Sulfate API Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Glucosamine Sulfate API Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Asia-Pacific Glucosamine Sulfate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 58. India Glucosamine Sulfate API Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Glucosamine Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 60. Central and South America Glucosamine Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Glucosamine Sulfate API Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Glucosamine Sulfate API Sales Volume (Tons) by Type (2021-2031)
 Figure 63. Central and South America Glucosamine Sulfate API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Glucosamine Sulfate API Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Central and South America Glucosamine Sulfate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Glucosamine Sulfate API Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Glucosamine Sulfate API Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Glucosamine Sulfate API Sales YoY (2020-2031) & (Tons)
 Figure 69. Middle East and Africa Glucosamine Sulfate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Glucosamine Sulfate API Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Glucosamine Sulfate API Sales Volume (Tons) by Type (2021-2031)
 Figure 72. South America Glucosamine Sulfate API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Glucosamine Sulfate API Sales Volume (Tons) by Application (2020-2031)
 Figure 74. Middle East and Africa Glucosamine Sulfate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Glucosamine Sulfate API Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Glucosamine Sulfate API Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Glucosamine Sulfate API Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Glucosamine Sulfate API Revenue (2020-2025) & (US$ Million)
 Figure 79. Glucosamine Sulfate API Industry Chain Mapping
 Figure 80. Regional Glucosamine Sulfate API Manufacturing Base Distribution (%)
 Figure 81. Global Glucosamine Sulfate API Production Market Share by Region (2020-2031)
 Figure 82. Glucosamine Sulfate API Production Process
 Figure 83. Regional Glucosamine Sulfate API Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Glucosamine Hydrochloride API Market Research Report 2024
Global Glucosamine Salts Market Research Report 2024
Global Glucosamine Chondroitin Supplements Market Research Report 2024
Global Glucosamine Sulfate Market Insights Forecast to 2030
Global Glucosamine Hydrochloride Market Research Report 2024
Global Glucosamine Market Research Report 2025
Global Kosher Glucosamine Market Research Report 2024
Global Natural Glucosamine Market Research Report 2025
Global Chondroitin Sulfate Market Research Report 2025
Global Pharma Grade Chondroitin Sulfate Market Research Report 2025
Global Food Grade Chondroitin Sulfate Market Research Report 2025
Chondroitin Sulfate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Feed Grade Chondroitin Sulfate Market Research Report 2025
Global Glucosamine Sulfate Sodium Chloride API Market Research Report 2024
Chondroitin Sulfate Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global D Glucosamine Hydrochloride Market Research Report 2024
Chondroitin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dogs Glucosamine Supplements Market Research Report 2024
Global N Sulfo Glucosamine Potassium Salt Market Insights Forecast to 2030
Global Chondroitin Sulafte Calcium Market Research Report 2024

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions